Longeviti was founded by a team of leading medical device industry executives, neuro surgeons, and biomedical engineers.
Our mission is to develop innovative platforms for complex brain surgery. These solutions return patients to anatomical normalcy while providing innovative functional neurotechnology.
Longeviti was founded by a team of leading medical device industry executives, neuro surgeons, biomedical engineers, healthcare administrators and other healthcare practitioners.
Jesse Christopher, a leader in cranial reconstruction, has over 20 years in medical devices. As Longeviti’s co-founder, he’s advanced neurotechnology, brought multiple FDA-cleared implants to market, and holds 10 patents. He actively supports the Life Sciences Advisory Board for the state of Maryland Department of Commerce and the Greater Baltimore Council.
Denise Genuit brings 25+ years in healthcare management, driving Longeviti’s growth to a $100M valuation. She oversees HR, finance, compliance, and investor relations. With roots in dentistry and leadership at UMD, Denise plays a key role in strategy and serves on industry committees, promoting innovation and community engagement.
Todd Johnson is a seasoned executive with over 30 years of experience in medical device sales and marketing. He has developed a national neurosurgery training program adapted by the SNS, Longeviti’s ClearFit Ultrasound APP course, and Longeviti U sales training. A former Stryker leader and award-winner, he drives company growth.
Brad Rabinovitz brings 15 years of MedTech experience, advancing neurotechnology through global partnerships. Since 2016, he’s led teams across R&D, Quality, and Business Development, launched three product platforms, and secured an ICD-10-PCS code. Brad holds 18+ patents—16 as inventor—including the first battery-powered device for remote brain mapping. He chairs Longeviti’s IP Committee.
Corbin Clawson has over a decade of experience in drug delivery and medical device development. He holds multiple patents and led the validation of a $1B+ autoinjector system. With engineering degrees from Virginia Tech and UC San Diego, he previously held leadership roles at MedImmune/AstraZeneca and DevaCell before joining Longeviti.
Neil has more than three decades of experience in advanced technology program management, manufacturing operations, business management and strategic consulting, information technology management and international standards development. He has worked in the biomedical, aerospace and defense, automotive, and service industries.
Dr. David Langer is an American neurosurgeon renowned as the Chair of Neurosurgery at Lenox Hill Hospital in New York City and Professor of Neurosurgery and Radiology at the Zucker School of Medicine at Hofstra/Northwell. He is internationally recognized for his expertise in cerebral revascularization and aneurysm surgery, and gained widespread public attention through his starring roles in Netflix’s "Lenox Hill" (2020) and "Emergency: NYC" (2023).
Timothy Scannell is a former Stryker President and COO with over 30 years of leadership in medical technology. He serves on multiple healthcare boards, including Insulet (Chair), Longeviti (Chair), and Masimo. A Notre Dame graduate and former football captain, Tim is dedicated to advancing innovation in neuroscience and patient care.
Dr. Jill Kalman is the Senior Vice President, Chief Medical Officer, and Deputy Physician-in-Chief at Northwell Health. An expert in congestive heart failure, she joined Northwell in 2014 and served as Executive Director of Lenox Hill Hospital responsible for the quality of patient care, safety, and day-to-day operations. Dr. Kalman was recognized as one of Modern Healthcare’s Top Women Leaders in Healthcare in 2023.
Gregory is a seasoned executive with 30+ years of financial management and operating expertise in both public and private companies. He served as CFO of K2M Group Holdings, Inc., NASDAQ KTWO, a spinal implant innovation company for more than 11 years and has worked as a financial consultant to start-up and development-stage companies in technology and medical device industries.
As a turnaround specialist with a long history working with medical firms specializing in orthopedics, Lew was the former Chief Financial Officer of Hazleton Laboratories, President of Kirshner Medical, Board Member of Interpore International, DJ Orthopedics, and Co-Founder and Director of K2M (KTWO) and American Osteomedix. In addition to serving as Longeviti’s former Chairman of the Board, he also serves as a board member for several public companies and startups and is a strategic adviser to K2M.
Longeviti partners with leading organizations to advance technology in neurosurgery.
